NCT00381121|Recruiting
University of Michigan "Nephrology Research BioBank"
Michigan Nephrology Research BioBank for Molecular Analysis of Renal Disease "Nephrology Research BioBank"
Loading search results
Michigan Nephrology Research BioBank for Molecular Analysis of Renal Disease "Nephrology Research BioBank"
Sponsor study identifier
observational
420
1 country
1
Study Start
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
August 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
September 26, 2006
Actual (reported)September 27, 2006
Actual (reported)August 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
August 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Individuals with a clinically indicated biopsy are recruited and/or surplus tissue that remains from past clinical interventions is obtained.
Renal disease patients undergoing diagnostic workup
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
Schmid H, Henger A, Kretzler M. Molecular approaches to chronic kidney disease. Curr Opin Nephrol Hypertens. 2006 Mar;15(2):123-9. doi: 10.1097/01.mnh.0000214770.11609.fb.
Tissue, blood, urine
Matthias Kretzler,, MD
University of Michigan
First Submitted
September 26, 2006
First Posted
September 27, 2006
Study Start
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2030
A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
August 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
April 24, 2025
Record last verified: 2025-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: